Orphanet Journal of Rare Diseases

Scope & Guideline

Pioneering research for the unheard.

Introduction

Immerse yourself in the scholarly insights of Orphanet Journal of Rare Diseases with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationORPHANET J RARE DIS / Orphanet J. Rare Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Orphanet Journal of Rare Diseases focuses on providing a platform for the dissemination of research related to rare diseases, encompassing clinical, genetic, therapeutic, and epidemiological studies. It aims to improve the understanding of rare diseases and enhance patient care through comprehensive research findings.
  1. Clinical Research on Rare Diseases:
    This includes studies that explore clinical presentations, treatment efficacy, and long-term outcomes of various rare diseases, contributing to improved management and care protocols.
  2. Genetic Characterization and Genomics:
    The journal emphasizes studies that delve into the genetic underpinnings of rare diseases, including mutation analysis, genotype-phenotype correlations, and the use of next-generation sequencing to enhance diagnostic accuracy.
  3. Patient-Centered Outcomes and Quality of Life:
    Research focusing on patient-reported outcomes, quality of life assessments, and the psychosocial impact of rare diseases on patients and their families is a core area, highlighting the importance of patient perspectives in treatment planning.
  4. Health Economics and Burden of Illness:
    The journal publishes studies that assess the economic impact of rare diseases, including cost-of-illness analyses and healthcare utilization, providing insights into the broader implications of these conditions on healthcare systems.
  5. Innovative Therapeutics and Treatment Approaches:
    Research on novel therapeutic interventions, including pharmacological treatments, gene therapies, and clinical trial methodologies to evaluate the effectiveness of new therapies for rare diseases.
  6. Multidisciplinary and Collaborative Approaches:
    The journal promotes interdisciplinary research that involves collaboration among clinicians, researchers, and patients, fostering a holistic approach to the study and management of rare diseases.
The journal is currently witnessing a rise in interest in several themes, reflecting the evolving landscape of rare disease research and its implications for clinical practice.
  1. Telemedicine and Remote Care:
    The COVID-19 pandemic has accelerated interest in telehealth solutions for managing rare diseases, leading to an increase in studies examining the effectiveness of remote consultations and digital health technologies.
  2. Patient Engagement and Advocacy:
    There is a growing focus on the role of patient advocacy groups and their influence on research priorities and treatment development, highlighting the importance of patient voices in shaping healthcare policies.
  3. Longitudinal and Natural History Studies:
    Research tracking the long-term progression of rare diseases is gaining traction, aiming to improve understanding of disease trajectories and inform future therapeutic strategies.
  4. Integration of Artificial Intelligence in Rare Disease Research:
    The application of AI and machine learning in analyzing large datasets for rare diseases is emerging, with studies exploring how these technologies can enhance diagnostics and treatment personalization.
  5. Health Disparities in Rare Diseases:
    An increasing emphasis on understanding the disparities in access to care and treatment outcomes among different populations affected by rare diseases is becoming more prevalent.

Declining or Waning

While the journal has grown and diversified in its research focus, certain themes appear to be declining in prominence over recent years. These waning scopes may reflect shifts in research priorities or advancements in other areas.
  1. Epidemiological Studies of Rare Diseases:
    There has been a noticeable decline in publications solely focused on the epidemiology of rare diseases, possibly due to the increasing integration of epidemiological data into broader studies that also consider genetic and clinical aspects.
  2. Traditional Case Reports:
    The frequency of traditional case reports has diminished as the journal increasingly emphasizes systematic reviews and larger cohort studies that provide more comprehensive data.
  3. Single-Country Focused Studies:
    Research that concentrates on rare diseases within a specific country is becoming less common, as there is a growing trend toward multi-national studies that provide a more global perspective on rare diseases.

Similar Journals

European Journal of Medical Genetics

Exploring the Intersection of Genetics and Medicine
Publisher: ELSEVIERISSN: 1769-7212Frequency: 4 issues/year

European Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.

Cold Spring Harbor Molecular Case Studies

Advancing molecular insights for clinical breakthroughs.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

CLINICAL DYSMORPHOLOGY

Unraveling the complexities of dysmorphic syndromes.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0962-8827Frequency: 4 issues/year

CLINICAL DYSMORPHOLOGY, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of anatomy, genetics, and pediatric health, with a significant focus on the study of congenital disorders and their phenotypic manifestations. Established in 1992, this esteemed journal has contributed valuable insights into the understanding of dysmorphic syndromes and their clinical implications, making it an essential resource for researchers, clinicians, and students alike. With an impact factor indicative of its robust scholarly influence, CLINICAL DYSMORPHOLOGY engages a diverse readership through specialized articles, case studies, and reviews that advance the knowledge of genetic conditions and associated anatomical anomalies. Although it operates under a non-open access model, the journal is highly regarded with a 2023 ranking of Q3 in Anatomy and Q4 in several other relevant categories, reflecting its ongoing commitment to quality research in the domain of clinical medicine. Researchers and professionals are encouraged to contribute to and explore the rich content of this journal as it continues to shape the discourse in dysmorphology and related fields until its expected convergence in 2024.

Boletin de Pediatria

Advancing Pediatric Knowledge for Healthier Futures
Publisher: EDICIONES ERGON SAISSN: 0214-2597Frequency: 4 issues/year

Boletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.

SAGE Open Medical Case Reports

Empowering Healthcare Through Open Insights
Publisher: SAGE PUBLICATIONS INCISSN: 2050-313XFrequency: 1 issue/year

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

ORVOSI HETILAP

Advancing Knowledge, Shaping Practices
Publisher: AKADEMIAI KIADO ZRTISSN: 0030-6002Frequency: 52 issues/year

ORVOSI HETILAP is a pivotal journal in the field of general medicine, published by AKADEMIAI KIADO ZRT in Hungary. With its rich history dating back to 1949, this journal has been a platform for disseminating significant research findings and clinical advancements that impact healthcare practices. Although it currently falls within the Q4 category in the 2023 ranking of Medicine (miscellaneous), it holds a Scopus rank of #320 among 636 journals in its category, indicating its growing recognition among peers and scholars. The journal does not offer open access options, which may limit broader dissemination, but it nonetheless remains an important resource for medical professionals, researchers, and students engaging with contemporary medical issues. Located in the vibrant academic landscape of Budapest, ORVOSI HETILAP continues to contribute to the evolving dialogue in the medical community, showcasing diverse topics and fostering interdisciplinary collaboration.

Case Reports in Oncology

Transforming Case Studies into Global Knowledge
Publisher: KARGERISSN: 1662-6575Frequency: 3 issues/year

Case Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.

Indian Journal of Rheumatology

Elevating the discourse in rheumatology for better health outcomes.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

ACR Open Rheumatology

Advancing rheumatology through open access innovation.
Publisher: WILEYISSN: Frequency: 12 issues/year

ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Exploring New Horizons in Dermatology and Venereology
Publisher: MASSON EDITEURISSN: 0151-9638Frequency: 12 issues/year

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.